Microencapsulation techniques to develop formulations of insulin for oral delivery: a review

References

• Agarwal V, Khan MA. Current status of the oral delivery of insulin. Pharm Technol 2001; 25(10)76–90
   Google Scholar
• Bai JP, Chang LL. Effects of enzyme inhibitors and insulin concentration on transepithelial transport of insulin in rats. J Pharm Pharmacol 1996; 48: 1078–82
   PubMed Web of Science ®Google Scholar
• Banting FG, Best CH, Collip JB, Campbell WR, Fletcher AA. Pancreatic extracts in the treatment of diabetes mellitus: Preliminary report. Reprint. Can Med Assoc J 1991; 145(10)1281–6
   PubMed Web of Science ®Google Scholar
• Bendayan M, Ziv E, Gingras D, Sasson RB, Bar-On H, Kidron M. Biochemical and cytochemical evidence for the intestinal absorption of insulin in control and diabetic rats. Comparison between the effectiveness of duodenal and colon mucosa. Diabetologia 1994; 37: 119–26
   PubMed Web of Science ®Google Scholar
• Bendayan M, Ziv E, Sasson RB, Bar-On H, Kidron M. Morpho-cytochemical and biochemical evidence for insulin absorption by the rat ileal epithelium. Diabetologia 1990; 33: 197–204
   PubMed Web of Science ®Google Scholar
• Chalasani KB, Russell JGJ, Jain AK, Diwan PV, Jain SK. Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles. J Control Release 2007b; 122: 141–50
   PubMed Web of Science ®Google Scholar
• Chalasani KB, Russell JGJ, Yandrapu SK, Diwan PV, Jain SK. A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin. J Control Release 2007a; 117: 421–9
   PubMed Web of Science ®Google Scholar
• Chang SG, Choi KD, Jang SH, Shin HC. Role of disulfide bonds in the structure and activity of human insulin. Mol Cells 2003; 16(3)323–30
   PubMed Web of Science ®Google Scholar
• Cilek A, Celebi N, Tirnaksiz F. Lecithin-based microemulsion of a peptide for oral administration: Preparation, characterization, and physical stability of the formulation. Drug Deliv 2006; 13(1)19–24
   PubMed Web of Science ®Google Scholar
• Cilek A, Celebi N, Tirnaksiz F, Tay A. A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats. Int J Pharm 2005; 298: 176–85
   PubMed Web of Science ®Google Scholar
• Constantinides PP, Scalart JP, Lancaster C, Marcello J, Marks G, Ellens H, Smith PL. Formulation and intestinal absorption enhancement evaluation of water in oil microemulsions incorporating medium-chain glycerides. Pharm Res 1994; 11: 1385–90
   PubMed Web of Science ®Google Scholar
• Cournarie F, Rosilio V, Cherón M, Vauthier C, Lacour V, Grossiord JL, Seiller M. Improved formulation of W/OW/multiple emulsion for insulin encapsulation. Influence of the chemical structure of insulin. Colloid Polym Sci 2004a; 282: 562–8
   Web of Science ®Google Scholar
• Cournarie F, Savelli MP, Rosilio V, Bretez F, Vauthier C, Grossiord JL, Seiller M. Insulin-loaded W/O/W multiple emulsions: Comparison of the performances of systems prepared with medium-chain triglycerides and fish oil. Eur J Pharm Biopharm 2004b; 58: 477–82
   PubMed Web of Science ®Google Scholar
• Cui F, Shi K, Zhang L, Tao A, Kawashima Y. Biodegradable nanoparticles loaded with insulin–phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation. J Control Release 2006; 114: 242–50
   PubMed Web of Science ®Google Scholar
• Cunha AS, Cherón M, Grossiord JL, Puisieux F, Seiller M. W/O/W multiple emulsions of insulin containing a protease inhibitor and an absorption enhancer: Biological activity after oral administration to normal and diabetic rats. Int J Pharm 1998; 169: 33–44
   Web of Science ®Google Scholar
• Cunha AS, Grossiord JL, Puisieux F, Seiller M. Insulin in w/o/w multiple emulsions: Preparation characterization and determination of stability towards proteases in vitro. J Microencapsul 1997a; 14(39)311–19
   PubMed Web of Science ®Google Scholar
• Cunha AS, Grossiord JL, Puisieux F, Seiller M. W/O/W multiple emulsions of insulin containing a protease inhibitor and an absorption enhancer: Preparation, characterization and determination of stability towards proteases in vitro. Int J Pharm 1997b; 158: 79–89
   Google Scholar
• Dai Y, Tang JG. Characteristic, activity and conformational studies of [A6-Ser, A11-Ser]-insulin. Biochim Biophys Acta 1996; 1296(1)63–8
   PubMedGoogle Scholar
• Dekel Y, Glucksam Y, Margalit R. Novel fibrillar insulin formulations for oral administration: Formulation and in vivo studies in diabetic mice. J Control Release 2010; 143: 128–35
   PubMed Web of Science ®Google Scholar
• El-Sayed A, Remawi MA, Qinna N, Farouk A, Badwan A. Formulation and characterization of an oily-based system for oral delivery of insulin. Eur J Pharm Biopharm 2009; 73: 269–79
   PubMed Web of Science ®Google Scholar
• Fasano A, Uzzau S. Modulation of intestinal tight junctions by zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. J Clin Invest 1997; 99: 1158–64
   PubMed Web of Science ®Google Scholar
• Foss AC, Goto T, Morishita M, Peppas NA. Development of acrylic-based copolymers for oral insulin delivery. Eur J Pharm Biopharm 2004; 57: 163–9
   PubMed Web of Science ®Google Scholar
• Graf A, Rades T, Hook SM. Oral insulin delivery using nanoparticles based on microemulsions with different structure-types: Optimisation and in vivo evaluation. Eur J Pharm Sci 2009; 37: 53–61
   PubMed Web of Science ®Google Scholar
• Harfenist EJ, Craig LC. The molecular weight of insulin. J Am Chem Soc 1952; 74: 3087–9
   Web of Science ®Google Scholar
• Hochman J, Artursson P. Mechanisms of absorption enhancement and tight junction regulation. J Control Release 1994; 29: 253–67
   Web of Science ®Google Scholar
• Hoffman A, Ziv E. Pharmacokinetic considerations of new insulin formulations and routes of administration. Clin Pharmacokinet 1997; 33: 285–301
   PubMed Web of Science ®Google Scholar
• Jain D, Panda AK, Majumdar DK. Eudragit S100 entrapped insulin microspheres for oral delivery. APPS PharmSciTech 2005; 688(1)100–7
   Google Scholar
• Jain S, Rathi VV, Jain AK, Das M, Godugu C. Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin. Nanomedicine 2012; 7(9)1–27
   PubMed Web of Science ®Google Scholar
• Jelvehgari M, Milani PZ, Shadbad MRS, Loveymi BD, Nokhodchi A, Azari Z, Valizadeh H. Development of pH-sensitive insulin nanoparticles using Eudragit L100-55 and chitosan with different molecular weights. AAPS PharmSciTech 2010; 11(3)1237–42
   PubMed Web of Science ®Google Scholar
• Kavimandan NJ, Peppas NA. Confocal microscopic analysis of transport mechanisms of insulin across the cell monolayer. Int J Pharm 2008; 354(1–2)143–8
   PubMedGoogle Scholar
• Kennedy FP. Recent developments in insulin delivery techniques: Current status and future potential. Drugs 1991; 42: 213–27
   PubMed Web of Science ®Google Scholar
• Kinesh VP, Neelam DP, Punit BP, Bhavesh SB, Pragna KS. Novel approaches for oral delivery of insulin and current status of oral insulin products. Int J Pharm Sci Nanotech 2010; 3(3)1057–64
   Google Scholar
• Krauland AH, Guggi D, Schnürch AB. Oral insulin delivery: The potential of thiolated chitosan-insulin tablets on non-diabetics rats. J Control Release 2004; 95: 547–55
   PubMed Web of Science ®Google Scholar
• Laskowski M, Haessler HA, Miech RP, Peanasky RJ, Laskowski M. Effect of trypsin inhibitor on passage of insulin across the intestinal barrier. Science 1958; 127: 1115–16
   PubMed Web of Science ®Google Scholar
• Lin YH, Mi FL, Chen CT, Chang WC, Peng SF, Liang HF, Sun HW. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules 2007; 8: 146–52
   PubMed Web of Science ®Google Scholar
• Liu R, Huang SS, Wan YH, Ma GH, Su ZG. Preparation of insulin-loaded PLA/PLGA microcapsules by a novel membrane emulsification method and its release in vitro. Colloids Surf B-Biointerfaces 2006; 51: 30–8
   PubMed Web of Science ®Google Scholar
• Lowman AM, Morishita M, Kajita M, Nagai T, Peppas NA. Oral delivery of Insulin using pH-responsive complexation gels. J Pharm Sci 1999; 88(9)933–7
   PubMed Web of Science ®Google Scholar
• Ma EL, Ma H, Liu Z, Zheng C, Duan M. In vitro and in vivo evaluation of a novel oral insulin formulation. Acta Pharmacol Sin 2006; 27(10)1382–8
   PubMed Web of Science ®Google Scholar
• Makhlof A, Tozuka Y, Takeuchi H. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci 2011; 42: 445–51
   PubMed Web of Science ®Google Scholar
• Marrero DG. Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus. Clin Cornerstone 2007; 8(2)33–43
   PubMedGoogle Scholar
• Marschütz MK, Caliceti P, Schnürch AB. Design and in vivo evaluation of an oral delivery system for insulin. Pharm Res 2000; 17(12)1468–74
   PubMed Web of Science ®Google Scholar
• Mathiowitz E, Furtado S, Abramson D, Burril R, Olivier G, Gourd C, Bubbers E. Oral delivery of insulin loaded poly(fumaric-co-sebacic) anhydride microspheres. Int J Pharm 2008; 347: 149–55
   PubMed Web of Science ®Google Scholar
• Morcol T, Nagappan P, Nerembum L, Mitchell A, Bell SJD. Calcium phosphate-PEG-insulin-casein (CAPIC) particles as oral delivery systems for insulin. Int J Pharm 2004; 277: 91–7
   PubMed Web of Science ®Google Scholar
• Morishita M, Goto T, Nakamura K, Lowman AM, Takayama K, Peppas NA. Novel oral insulin delivery systems based on complexation polymer hydrogels: Single and multiple administration studies in type 1 and 2 diabetic rats. J Control Release 2006; 110: 587–94
   PubMed Web of Science ®Google Scholar
• Morishita M, Matsuzawa A, Takayama K, Isowa K, Nagai T. Improving insulin enteral absorption using water-in-oil-in-water emulsion. Int J Pharm 1998; 172: 189–98
   Web of Science ®Google Scholar
• Morishita I, Morishita M, Takayama K, Mashida Y, Nagai T. Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats. Int J Pharm 1992a; 92: 9–16
   Web of Science ®Google Scholar
• Morishita M, Morishita I, Takayama K, Machida Y, Nagai T. Novel oral microspheres of insulin with protease inhibitor protecting from enzymatic degradation. Int J Pharm 1992b; 78: 1–7
   Web of Science ®Google Scholar
• Mukherjee B, Santra K, Pattnaik G, Ghosh S. Preparation, characterization and in vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers. Int J Nanomed 2008; 3(4)487–96
   PubMed Web of Science ®Google Scholar
• Musabayane CT, Munjeri O, Bwititi P, Osim EE. Orally administered, insulin-loaded amidated pectin hydrogel beads sustain plasma concentrations of insulin in streptozotocin-diabetic rats. J Endocrinol 2000; 164: 1–6
   PubMed Web of Science ®Google Scholar
• Park K, Kwon IC, Park K. Oral protein delivery: Current status and future prospect. React Funct Polym 2011; 71: 280–7
   Web of Science ®Google Scholar
• Ritschel WA. Microemulsions for improved peptide absorption from gastrointestinal tract. Meth Find Exp Clin Pharmacol 1991; 13: 205–20
   PubMed Web of Science ®Google Scholar
• Ryle AP, Sanger F, Smith LF, Kitai R. The disulphide bonds of insulin. Biochem J 1955; 60: 542–56
   Web of Science ®Google Scholar
• Sajeesh S, Sharma CP. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int J Pharm 2006; 325(1–2)147–54
   PubMed Web of Science ®Google Scholar
• Sanger F. The terminal peptides of insulin. Biochem J 1949; 45: 563–74
   PubMed Web of Science ®Google Scholar
• Sanger F. Chemistry of insulin: Determination of the structure of insulin opens the way to greater understanding of life processes. Science 1959; 129: 1340–4
   PubMedGoogle Scholar
• Sarmento B, Martins S, Ferrerira D, Souto EB. Oral insulin delivery by means of solid lipids nanoparticles. Int J Nanomed 2007a; 2(4)743–9
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, Ferreira D. Development and characterization of new insulin containing polysaccharide nanoparticles. Colloids Surf B-Biointerfaces 2006; 53: 193–202
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, Ferreira D, Neufeld R. Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules 2007b; 8: 3054–60
   PubMed Web of Science ®Google Scholar
• Sharma G, Wilson K, Van der Walle CF, Sattar N, Petrie JR, Ravi Kumar MNV. Microemulsions for oral delivery of insulin: Design, development and evaluation in streptozotocin induced diabetic rats. Eur J Pharm Biopharm 2010; 76: 159–69
   PubMed Web of Science ®Google Scholar
• Sheeja VS, Reddy MH, Joseph J, Reddy ND. Insulin therapy in diabetes management. Int J Pharm Sci Rev Res 2010; 2(2)98–105
   Google Scholar
• Shilling RJ, Mitra AK. Intestinal mucosa transport of insulin. Int J Pharm 1990; 62: 53–64
   Google Scholar
• Shima M, Tanaka M, Fujii T, Egawa K, Kimura Y, Adachi S, Matsuno R. Oral administration of insulin included in fine W/O/W emulsions to rats. Food Hydrocolloids 2006; 20: 523–31
   Web of Science ®Google Scholar
• Silva CM, Ribeiro AJ, Ferreira D, Veiga F. Insulin encapsulation in reinforced alginate microspheres prepared by internal gelation. Eur J Pharm Sci 2006; 29: 148–59
   PubMed Web of Science ®Google Scholar
• Singh S, Patel D, Patel NR, Kumar K, Gautam MK. Insulin oral delivery may be possible. Int J Pharm Prof Res 2010; 1(1)46–51
   Google Scholar
• Singnurkar PS, Gidwani SK. Insulin-egg yolk dispersions in self microemulsifying system. Indian J Pharm Sci 2008; 70(6)727–32
   PubMed Web of Science ®Google Scholar
• Touitou E, Rubinstein A. Targeted enteral delivery of insulin to rats. Int J Pharm 1986; 30: 95–9
   Web of Science ®Google Scholar
• Tozaki H, Emi Y, Horisaka E, Fujita T, Yamamoto A, Muranishi S. Degradation of insulin and calcitonin and their protection by various protease inhibitors in rat caecal contents: Implications in peptide delivery to the colon. J Pharm Pharmacol 1997; 49(2)164–8
   PubMed Web of Science ®Google Scholar
• Trenktrog T, Muller BW, Seifert J. In vitro investigation into enhancement of intestinal peptide absorption by emulsion systems. Eur J Pharm Biopharm 1995; 41: 284–90
   Web of Science ®Google Scholar
• Watnasirichaikul S, Rades T, Tucker IG, Davies NM. In-vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion. J Pharm Pharmacol 2002; 54: 473–80
   PubMed Web of Science ®Google Scholar
• Woitiski CB, Neufeld RJ, Veiga F, Carvalho RA, Figueiredo IV. Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticle. Eur J Pharm Sci 2010; 41: 556–63
   PubMed Web of Science ®Google Scholar
• Wu ZM, Zhou L, Guo XD, Jiang W, Ling L, Qian Y, Luo KQ, Zhang LJ. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin. Int J Pharm 2012; 425: 1–8
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Taniguchi T, Rikyuu K, Tsuji T, Fujita T, Murakami M, Muranishi S. Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm Res 1994; 11(10)1496–500
   PubMed Web of Science ®Google Scholar
• Yang SZ, Huang YD, Jie XF, Feng YM, Niu JY. Relationship between insulin A chain regions and insulin biological activities. World J Gastroenterol 2000; 6(3)371–3
   PubMed Web of Science ®Google Scholar
• Yin L, Ding J, He C, Cui L, Tan C, Yin C. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials 2009; 30: 5691–700
   PubMed Web of Science ®Google Scholar
• Zhang X, Sun M, Zheng A, Cao D, Bi Y, Sun J. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Eur J Pharm Sci 2012a; 45: 632–8
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wei W, Lv P, Wang L, Ma G. Preparation and evaluation of alginate–chitosan microspheres for oral delivery of insulin. Eur J Pharm Biopharm 2011; 77: 11–19
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wu X, Meng L, Zhang Y, Ai R, Qi N, He H, Xu H, Tang X. Thiolated Eudragit nanoparticles for oral insulin delivery: Preparation, characterization and in vivo evaluation. Int J Pharm 2012b; 436: 341–50
   PubMed Web of Science ®Google Scholar